Topic:
Infectious Diseases
Latest Headlines
Latest Headlines
Polio vaccine dose reductions could cut costs
A partial dose of the polio vaccine works just as well as a full one in providing a basic level of immunity against the disease, a new study shows.
CDC: Adult vaccination rates 'unacceptably low'
Analysts expect the U.S. vaccine market to rack up to $12.8 billion in sales for 2012. And Transparency Market Research says the industry can expect to see 5.3% growth through 2018. But low vaccination rates among U.S. adults may hamper that upward trend.
Researchers set to resume lab-bred bird flu studies
Just more than a year after putting a voluntary moratorium on certain experiments involving the H5N1 avian influenza virus, researchers say the studies should restart.
Study: Almost half of U.S. children get vaccines late
Almost half of all babies and toddlers in the United States aren't receiving vaccines on time, a new study shows.
Vaccine stakes upped as dengue dubbed fastest-spreading tropical disease
Many drug developers have tried and all have failed to create a vaccine for potentially fatal, flu-like dengue. And now the stakes are higher, as the World Health Organization just deemed dengue the world's fastest-spreading tropical disease, representing a pandemic threat.
Widespread, early flu season grips United States
A fast, early and widespread flu season has gripped the United States, though deaths and hospitalizations are still below pandemic thresholds.
Altravax pulls in $1.2M from NIH
NIH's National Institute of Allergy and Infectious Diseases has its eye on Altravax, awarding the company $1.2 million to advance a dengue vaccine and hepatitis B therapeutic.
Pfizer wins Prevenar 13 expansion in EU
Pfizer has always harbored substantial goals for its pneumococcal conjugate vaccine, and the pharma giant got a leg up Tuesday when the European Commission approved the use of Prevenar 13 in older children and adolescents.
Typhoid vaccine recall results in shortage in U.K.
A typhoid vaccine recall issued back in October by Sanofi Pasteur MSD--a joint venture of pharma giants Sanofi and Merck--has resulted in a shortage of the injection in the United Kingdom.
Serum Institute will donate measles rubella vaccine to GAVI
The Serum Institute of India will donate 20 million doses of measles-rubella vaccine to the GAVI Alliance as part of that organization's initiative to reduce the mortality rate caused by measles-rubella in the developing world.
